Effects of erlotinib therapy on [(11)C]erlotinib uptake in EGFR mutated, advanced NSCLC

BACKGROUND: In non-small cell lung cancer (NSCLC) patients off erlotinib therapy, positron emission tomography (PET) using [(11)C]erlotinib distinguished epidermal growth factor receptor (EGFR) mutations from wild-type EGFR. However, tumor uptake of [(11)C]erlotinib during erlotinib therapy is unkno...

Descripción completa

Detalles Bibliográficos
Autores principales: Bahce, Idris, Yaqub, Maqsood, Errami, Hanane, Schuit, Robert C., Schober, Patrick, Thunnissen, Erik, Windhorst, Albert D., Lammertsma, Adriaan A., Smit, Egbert F., Hendrikse, N. Harry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4746207/
https://www.ncbi.nlm.nih.gov/pubmed/26857779
http://dx.doi.org/10.1186/s13550-016-0169-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4746207/
https://www.ncbi.nlm.nih.gov/pubmed/26857779
http://dx.doi.org/10.1186/s13550-016-0169-8

Ejemplares similares